Author/Creator: Liffick, Emily - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Liffick, Emily

1. Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study. (20th November 2019)

Authors:: Wilbraham, Darren; Berg, Paul H.; Tsai, Max; Liffick, Emily; Loo, Li Shen; Doty, Erin Gautier; Sellers, Edward
Journal:: Journal of clinical pharmacology
Issue:: Volume 60:Number 4(2020)
Page Start:: 495
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Characterization of white matter abnormalities in early‐stage schizophrenia. Issue 4 (13th September 2016)

Authors:: Hummer, Tom A.; Francis, Michael M.; Vohs, Jenifer L.; Liffick, Emily; Mehdiyoun, Nicole F.; Breier, Alan
Journal:: Early intervention in psychiatry
Issue:: Volume 12:Issue 4(2018:Aug.)
Page Start:: 660
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Metacognitive Capacity as a Predictor of Insight in First-Episode Psychosis. Issue 5 (May 2015)

Authors:: Vohs, Jenifer L.; Lysaker, Paul H.; Liffick, Emily; Francis, Michael M.; Leonhardt, Bethany L.; James, Alison; Buck, Kelly D.; Hamm, Jay A.; Minor, Kyle S.; Mehdiyoun, Nikki; Breier, Alan
Journal:: Journal of nervous and mental disease
Issue:: Volume 203:Issue 5(2015:May)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Metacognitive Capacity as a Predictor of Insight in First-Episode Psychosis. Issue 5 (May 2015)

Authors:: Vohs, Jenifer L.; Lysaker, Paul H.; Liffick, Emily; Francis, Michael M.; Leonhardt, Bethany L.; James, Alison; Buck, Kelly D.; Hamm, Jay A.; Minor, Kyle S.; Mehdiyoun, Nikki; Breier, Alan
Journal:: Journal of nervous and mental disease
Issue:: Volume 203:Issue 5(2015:May)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. O12.3. EFFECTS OF FINGOLIMOD, A POTENT ANTI-INFLAMMATORY AGENT, ON BRAIN STRUCTURE, FUNCTION, AND SYMPTOMS IN SCHIZOPHRENIA. (9th April 2019)

Authors:: Breier, Alan; Hummer, Tom; Vohs, Jennifer; Mehdyoun, Nicole; Liffick, Emily; Francis, Michael
Journal:: Schizophrenia bulletin
Issue:: Volume 45(2019)Supplement 2
Page Start:: S198
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. P1‐039: LANABECESTAT DOES NOT AFFECT PHARMACOKINETICS OF THE BCRP SUBSTRATE ROSUVASTATIN. (1st July 2006)

Authors:: Monk, Scott A.; Andersen, Scott W.; Ayan-Oshodi, Mosun; Guo, Yingying; Hillgren, Kathleen M.; James, Douglas E.; Liffick, Emily; Willis, Brian A.
Journal:: Alzheimer's & dementia
Issue:: Volume 14:Supplement 7S(2018)Part 5
Page Start:: P282
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA?. (18th May 2020)

Authors:: Breier, Alan; Liffick, Emily; Hummer, Tom; Vohs, Jennifer; Mehdiyoun, Nicole; Yang, Ziyi; Saykin, Andrew J; McDonald, Brenna; Francis, Michael
Journal:: Schizophrenia bulletin
Issue:: Volume 46(2020)Supplement 1
Page Start:: S43
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN. (July 2019)

Authors:: Krege, John H; Rizzoli, Paul B; Liffick, Emily; Doty, Erin G; Dowsett, Sherie A; Wang, Jianing; Buchanan, Andrew S
Journal:: Cephalalgia
Issue:: Volume 39:Number 8(2019)
Page Start:: 957
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗